The story of the erectile dysfunction drug presents a intricate picture for investors. While the initial release generated substantial gains, the end of its patent opened the floodgates to off-brand competitors, https://total-bookmark.com/story21488094/viagra-and-the-pharmaceutical-industry-a-precarious-opportunity